100% oxygen inhalation protects against zymosan-induced sterile sepsis in mice: The roles of inflammatory cytokines and antioxidant enzymes

Shock

Volumn 32, Issue 4, 2009, Pages 451-460

  Hou, Lichao ^a   Xie, Keliang ^a   Li, Nan ^a   Qin, Mingzhe ^a   Lu, Yan ^a   Ma, Shirong ^a   Ji, Genlin ^a   Xiong, Lize ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

100 oxygen; Antioxidant enzyme; Inflammatory cytokine; Multiple organ dysfunction syndrome; Sepsis; Sterile

Indexed keywords

CYTOKINE; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTERIAL GAS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; OXYGEN BREATHING; OXYGEN THERAPY; PROTECTION; SEPSIS; SURVIVAL RATE; TISSUE OXYGENATION; TREATMENT DURATION;

ADMINISTRATION, INHALATION; ANIMALS; CATALASE; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTATHIONE PEROXIDASE; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MICE; OXIDOREDUCTASES; OXYGEN; SEPSIS; SUPEROXIDE DISMUTASE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 70349679098     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31819c391a     Document Type: Article

References (37)

1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States frome 1979 through 2000. N Engl J Med 348:1546-1554, 2003.
2. Russell JA: Management of sepsis. N Engl J Med 355:1699-1713, 2006.
3. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150, 2003.
4. Bone RC: Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125:680-687, 1996.
5. Kaneider NC, Agarwal A, Leger AJ, Kuliopulos A: Reversing systemic inflammatory response syndrome with chemokine receptor pepducins. Nat Med 11:661-665, 2005.
6. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377, 2001.
7. Cuzzocrea S, Imperatore F, Costantino G, Luongo C, Mazzon E, Scafuro MA, Mangoni G, Caputi AP, Rossi F, Filippelli A: Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat. Shock 13:197-203, 2000.
8. Folz RJ, Abushamaa AM, Suliman HB: Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 103:1055-1066, 1999.
9. Altemeier WA, Sinclair SE: Hyperoxia in the intensive care unit: why more is not always better. Curr Opin Crit Care 13:73-78, 2007.
10. Barth E, Bassi G, Maybauer DM, Simon F, Gröger M, Oter S, Speit G, Nguyen CD, Hasel C, Möller P, et al.: Effects of ventilation with 100% oxygen during early hyperdynamic porcine fecal peritonitis. Crit Care Med 36:495-503, 2008.
11. Meier J, Pape A, Lauscher P, Zwissler B, Habler O: Hyperoxia in lethal methemoglobinemia: effects on oxygen transport, tissue oxygenation, and survival in pigs. Crit Care Med 33:1582-1588, 2005.
12. Meier J, Kemming GI, Kisch-Wedel H, Blum J, Pape A, Habler OP: Hyperoxic ventilation reduces six-hour mortality after partial fluid resuscitation from hemorrhagic shock. Shock 22:240-247, 2004.
13. Efrati S, Berman S, Ben Aharon G, Siman-Tov Y, Averbukh Z, Weissgarten J: Application of normobaric hyperoxia therapy for amelioration of haemorrhagic shock-induced acute renal failure. Nephrol Dial Transplant 23:2213-2222, 2008.
14. Volman TJ, Hendriks T, Goris RJ: Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 23:291-297, 2005.
15. Goris RJ, Boekholtz WK, van Bebber IP, Nuytinck JK, Schillings PH: Multiple organ failure and sepsis without bacteria. An experimental model. Arch Surg 121:897-901, 1986.
16. Ferrer TJ, Webb JW, Wallace BH, Bridges CD, Palmer HE, Robertson RD, Cone JB: Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS). J Surg Res 77:157-164, 1998.
17. Protti A, Singer M: Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care 10:228, 2006.
18. Brahimi-Horn MC, Pouysségur J: Oxygen, a source of life and stress. FEBS Lett 581:3582-3591, 2007.
19. Jamieson D, Chance B, Cadenas E, Boveris A: The relation of free radical production to hyperoxia. Annu Rev Physiol 48:703-719, 1986.
20. Shi C, Andersson R, Zhao X, Wang X: Potential role of reactive oxygen species in pancreatitis-associated multiple organ dysfunction. Pancreatology 5:492-500, 2005.
21. Morrow DM, Entezari-Zaher T, Romashko III J, Azghani AO, Javdan M, Ulloa L, Miller EJ, Mantell LL: Antioxidants preserve macrophage phagocytosis of Pseudomonas aeruginosa during hyperoxia. Free Radic Biol Med 9:1338-1349, 2007.
22. Knighton DR, Halliday B, Hunt TK: Oxygen as an antibiotic. The effect of inspired oxygen on infection. Arch Surg 119:199-204, 1984.
23. Greif R, Akça O, Horn EP, Kurz A, Sessler DI: Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N Engl J Med 342:161-167, 2000.
24. Bitterman H, Brod V, Weisz G, Kushnir D, Bitterman N: Effects of oxygen on regional hemodynamics in hemorrhagic shock. Am J Physiol 271:H203-H211, 1996.
25. Brod VI, Krausz MM, Hirsh M, Adir Y, Bitterman H: Hemodynamic effects of combined treatment with oxygen and hypertonic saline in hemorrhagic shock. Crit Care Med 34:2784-2791, 2006.
26. Sukhotnik I, Krausz MM, Brod V, Balan M, Turkieh A, Siplovich L, Bitterman H: Divergent effects of oxygen therapy in four models of uncontrolled hemorrhagic shock. Shock 18:277-284, 2002.
27. Dong H, Xiong L, Zhu Z, Chen S, Hou L, Sakabe T: Preconditioning with hyperbaric oxygen and hyperoxia induces tolerance against spinal cord ischemia in rabbits. Anesthesiology 96:907-912, 2002.
28. Buras JA, Holt D, Orlow D, Belikoff B, Pavlides S, Reenstra WR: Hyperbaric oxygen protects from sepsis mortality via an interleukin-10-dependent mechanism. Crit Care Med 34:2624-2629, 2006.
29. Pinsky MR: Pathophysiology of sepsis and multiple organ failure: pro- versus anti-inflammatory aspects. Contrib Nephrol 144:31-43, 2004.
30. Ashare A, Powers LS, Butler NS, Doerschug KC, Monick MM, Hunninghake GW: Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am J Physiol Lung Cell Mol Physiol 288:L633-L640, 2005.
31. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al.: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251, 1999.
32. Sha Y, Zmijewski J, Xu Z, Abraham E: HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 180:2531-2537, 2008.
33. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, et al.: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565-570, 2000.
34. Yoshikawa T, Takano H, Takahashi S, Ichikawa H, Kondo M: Changes in tissue antioxidant enzyme activities and lipid peroxides in endotoxin-induced multiple organ failure. Circ Shock 42:53-58, 1994.
35. Cuzzocrea S, McDonald MC, Mazzon E, Filipe HM, Centorrino T, Lepore V, Terranova ML, Ciccolo A, Caputi AP, Thiemermann C: Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat. Crit Care Med 29:102-111, 2001.
36. van Bebber IP, Boekholz WK, Goris RJ, Schillings PH, Dinges HP, Bahrami S, Redl H, Schlag G: Neutrophil function and lipid peroxidation in a rat model of multiple organ failure. J Surg Res 47:471-475, 1989.
37. Clerch LB, Massaro D, Berkovich A: Molecular mechanisms of antioxidant enzyme expression in lung during exposure to and recovery from hyperoxia. Am J Physiol 274:L313-L319, 1998.